UK biotechs pursue China R&D access, capital, and clinical partnerships
Nine UK life sciences companies traveled to Shanghai in October as part of a three-day trade mission, seeking clinical trial partnerships, laboratory collaborations, and Chinese venture capital — not just market entry.
3 MIN READ · 17 OCT
Subscriber Content
Subscribe to read the full analysis
Subscribe to read everything on GATE86
Already a subscriber? Log in
Next in Today's signals
ECONOMY
Robin Xing outlines US$12 trillion industrial bet and China's deflation trap
3 MIN READ · 17 OCT
Related
INDUSTRY · MOBILITY & EV
XPeng opens vehicle platforms, chips and engineering tools to global partners
INDUSTRY · SEMICONDUCTORS
ASML China sales surge as domestic EUV challenger makes debut
INDUSTRY · AI & DIGITAL
Ant Group and rivals race to commercialise AI healthcare in China
In this story
Today's signals
Robin Xing outlines US$12 trillion industrial bet and China's deflation trap
3 MIN · 17 OCTXi Jinping's top military body is down to two members
3 MIN · 17 OCTChina's chip exports hit US$45 billion in September as trade breaks records
3 MIN · 17 OCTXPeng opens vehicle platforms, chips and engineering tools to global partners
3 MIN · 17 OCTASML China sales surge as domestic EUV challenger makes debut
3 MIN · 17 OCTChina cuts NEV export rebate from 13% to 9%, effective April 2027
3 MIN · 17 OCT
In this story
Today's signals
Robin Xing outlines US$12 trillion industrial bet and China's deflation trap
3 MIN · 17 OCTXi Jinping's top military body is down to two members
3 MIN · 17 OCTChina's chip exports hit US$45 billion in September as trade breaks records
3 MIN · 17 OCTXPeng opens vehicle platforms, chips and engineering tools to global partners
3 MIN · 17 OCTASML China sales surge as domestic EUV challenger makes debut
3 MIN · 17 OCTChina cuts NEV export rebate from 13% to 9%, effective April 2027
3 MIN · 17 OCT